je.st
news
Tag: merck
Germany's Merck cautious after deal spree
2015-03-03 10:15:59| Chemicals - Topix.net
Germany's Merck KGaA forecasts little or no improvement in earnings this year after a slight drop in fourth-quarter net profit, with stiff competition for its blockbuster multiple-sclerosis treatment and higher research spending likely to offset the impact of recent acquisitions. Multiple-sclerosis drug Rebif faces strong competition in North America and Europe while Merck continues to spend on developing new cancer treatments.
Tags: deal
cautious
merck
spree
Merck to Present at the 35th Annual Cowen Health Care Conference
2015-03-02 14:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that Adam Schechter, executive vice president and president, Global Human Health, Merck, is scheduled to present at the 35th Annual Cowen Health Care Conference in Boston on Mar. 3, 2015 at 8:40 a.m. EST. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at http://www.merck.com/investors/events-and-presentations/home.html. Language: English Contact: MerckMediaLainie Keller, 908-236-5036orInvestorJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: health
care
present
annual
Merck Announces Second-Quarter 2015 Dividend
2015-02-24 18:51:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.45 per share of the companys common stock for the second quarter of 2015. Payment will be made on Apr. 8, 2015, to stockholders of record at the close of business on Mar. 16, 2015. About Merck Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orInvestors:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: announces
dividend
merck
announces dividend
Merck grants free license for pediatric HIV drug
2015-02-24 09:51:20| Biotech - Topix.net
Drugmaker Merck & Co. has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus.
Tags: free
license
drug
grants
Merck Announces Collaboration with the Medicines Patent Pool to Expand Access to Pediatric Formulations of Raltegravir in Developing Countries
2015-02-24 09:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced an agreement with the Medicines Patent Pool (MPP) to license its pediatric formulations of raltegravir for use in treating HIV-1 infection in infants and children from four weeks to under 12 years of age in developing countries. This is the MPPs first agreement to provide access to an HIV integrase inhibitor for use in combination HIV therapy for infants and children in this age range. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558Ian McConnell, 908-740-1921orInvestors:Joe Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: access
countries
expand
pool
Sites : [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] next »